Pharmafile Logo

Kath Kerry

SWITCHED ONcology Patient Experience Focus Group Full Discussion

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In...

Havas Lynx

SWITCHED ONcology Patient Experience Focus Group Highlights

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. "We...

Havas Lynx

- PMLiVE

CTI slumps as Servier-partnered lymphoma drug fails

After major setback CTI, has promising myelofibrosis candidate to fall back on

Creativity has lost its worth

Creativity has lost its worth, and sadly it is undermining effectiveness

Page & Page Health

Healthcare Comms appointments

Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWAWorldHealth London sees Andy Hayley and Dick Dunford return

- PMLiVE

NHS England says yes to Roche’s Hemlibra

But stalls on funding for Actelion's Uptravi

- PMLiVE

Communiqué: big wins for obesity and sugar tax campaigners

More highlights from healthcare communications awards

- PMLiVE

Abingworth raises $315m to expand hunt for promising biotechs

New fund earmarked for early to late-stage European and US firms

Training the next generation of biotech leaders

Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy,...

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links